Multi-center randomized open label phase II trial on three rituximab dosing schemes in immune thrombocytopenia patients

被引：20

作者：

Zwaginga, Jaap J. ^{[1
,2
]}

van der Holt, Bronno ^{[3
]}

te Boekhorst, Peter A. ^{[5
]}

Biemond, Bart J. ^{[4
]}

Levin, Mark-David ^{[6
]}

van der Griend, Rene ^{[9
]}

Brand, Anneke ^{[1
,2
]}

Zweegman, Sonja ^{[8
]}

Pruijt, Hans F. M. ^{[10
]}

Novotny, Vera M. J. ^{[13
]}

Vreugdenhil, Art ^{[7
]}

de Groot, Marco R. ^{[14
]}

de Weerdt, Okke ^{[11
,21
]}

van Pampus, Elisabeth C. M. ^{[12
]}

van Maanen-Lamme, Tanja M. ^{[15
]}

Wittebol, Shulamiet ^{[16
]}

Schipperus, Martin R. ^{[17
]}

Silbermann, Matthijs H. ^{[18
]}

Huijgens, Peter C. ^{[8
]}

Luten, Marleen ^{[3
]}

Hollestein, Rene ^{[3
]}

Brakenhoff, Jan A. C. ^{[19
]}

Schrama, Jolanda G. ^{[20
]}

Valster, Fransje A. A. ^{[21
]}

Velders, Gerjo A. ^{[22
]}

Koene, Harry R. ^{[11
,21
]}

机构：

[1] Leiden Univ, Med Ctr, Dept Immunohematol & Blood Transfus, NL-2300 RA Leiden, Netherlands

[2] Leiden Univ, Med Ctr, Sanquin, Jon J van Rood Ctr Clin Transfus Res, NL-2300 RA Leiden, Netherlands

[3] Erasmus MC, Inst Canc, Clin Trial Ctr, HOVON Data Ctr, Rotterdam, Netherlands

[4] Acad Med Ctr Amsterdam, Dept Hematol, Amsterdam, Netherlands

[5] Erasmus MC, Dept Hematol, Rotterdam, Netherlands

[6] Albert Schweitzer Hosp, Dept Internal Med, Dordrecht, Netherlands

[7] Maxima Med Ctr, Dept Internal Med, Veldhoven, Netherlands

[8] Vrije Univ Amsterdam, Med Ctr, Dept Hematol, Amsterdam, Netherlands

[9] Diakonessen Hosp, Dept Internal Med, Utrecht, Netherlands

[10] Jeroen Bosch Hosp, Dept Internal Med, Den Bosch, Netherlands

[11] St Antonius Hosp, Dept Internal Med, Nieuwegein, Netherlands

[12] Radboud Univ Nijmegen, Med Ctr, Dept Lab Med, NL-6525 ED Nijmegen, Netherlands

[13] Radboud Univ Nijmegen, Med Ctr, Dept Hematol, NL-6525 ED Nijmegen, Netherlands

[14] Med Spectrum Twente, Dept Internal Med, Enschede, Netherlands

[15] Westfriesgasthuis, Dept Internal Med, Hoorn, Netherlands

[16] Meander Hosp, Dept Internal Med, Amersfoort, Netherlands

[17] HagaZiekenhuis, Dept Internal Med, The Hague, Netherlands

[18] Tergooiziekenhuizen, Dept Internal Med, Blaricum, Netherlands

[19] Waterland Hosp, Purmerend, Netherlands

[20] Spaarne Hosp, Dept Internal Med, Hoofddorp, Netherlands

[21] Lievensberg Hosp, Dept Internal Med, Bergen Op Zoom, Netherlands

[22] Gelderse Vallei Hosp, Dept Internal Med, Ede, Netherlands

来源：

HAEMATOLOGICA | 2015年 / 100卷 / 03期

关键词：

immune thrombocytopenia; rituximab; splenectomy delaying; early response; open label phase II; ADULT PATIENTS; PURPURA; SPLENECTOMY; THERAPY; EFFICACY; SAFETY; CHILDREN;

D O I：

10.3324/haematol.2014.110213

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：E90 / E92

页数：3

共 50 条

[21] A Pilot Open-Label Phase II Trial of Rituximab for Non-Criteria Manifestations of Antiphospholipid Syndrome [J].

Erkan, Doruk ;

Vega, JoAnn ;

Ramon, Glendalee ;

Kozora, Elizabeth ;

Lockshin, Michael D. .

ARTHRITIS AND RHEUMATISM, 2013, 65 (02) :464-471

[22] The Effects of Japanese Encephalitis Vaccine and Accelerated Dosing Scheduling on the Immunogenicity of the Chimeric Yellow Fever Derived Tetravalent Dengue Vaccine: A Phase II, Randomized, Open-Label, Single-Center Trial in Adults Aged 18 to 45 Years in the United States [J].

Glass, Aaron ;

Polhemus, Mark ;

Wang, Dongliang ;

Jarman, Richard G. ;

Thomas, Stephen J. ;

Friberg, Heather ;

Currier, Jeffrey R. ;

Bonaparte, Matthew ;

De la Barra, Rafael ;

Princiotta, Michael F. ;

Abbott, Mark ;

Cuzzo, Brian ;

Machabert, Tifany ;

Sridhar, Saranya ;

Endy, Timothy P. .

JOURNAL OF INFECTIOUS DISEASES, 2020, 221 (07) :1057-1069

[23] Interventions do not enhance medication persistence and compliance in patients with overactive bladder: a 24 weeks, randomised, open-label, multi-center trial [J].

Sung, H. H. ;

Han, D. H. ;

Kim, T. H. ;

Lee, Y. -S. ;

Lee, H. N. ;

Seo, J. T. ;

Choo, M. -S. ;

Lee, K. -S. .

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2015, 69 (11) :1309-1315

[24] Standard-Intensity Versus Low-Intensity Anticoagulation with Warfarin in Asian Patients with Atrial Fibrillation: A Multi-Center, Randomized Controlled Trial [J].

Cho, Jeong Gwan ;

Lee, Ki Hong ;

Kim, Yoo Ri ;

Kim, Sunah ;

Gwak, Jisoo ;

Cho, Eunbit ;

Sin, Yourim ;

Shin, Seung Yong ;

Park, Hyung Wook ;

Ko, Jum Suk ;

Kim, Nam Ho ;

Park, Yae Min ;

Lee, Jung Myung ;

Yoon, Nam Sik ;

Kim, Sung Soo ;

Kim, Jun Hyung ;

Kim, Dong Min .

CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2023, 29

[25] Effects of live music during chemotherapy in lymphoma patients: a randomized, controlled, multi-center trial [J].

Bro, Margrethe Langer ;

Johansen, Christoffer ;

Vuust, Peter ;

Enggaard, Lisbeth ;

Himmelstrup, Bodil ;

Mourits-Andersen, Torben ;

Brown, Peter ;

d'Amore, Francesco ;

Andersen, Elisabeth Anne Wreford ;

Abildgaard, Niels ;

Gram, Jeppe .

SUPPORTIVE CARE IN CANCER, 2019, 27 (10) :3887-3896

[26] A Phase II, Multicenter, Open-Label Study of Obatoclax Mesylate in Patients With Previously Untreated Myelodysplastic Syndromes With Anemia or Thrombocytopenia [J].

Arellano, Martha L. ;

Borthakur, Gautam ;

Berger, Mark ;

Luer, Jill ;

Raza, Azra .

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2014, 14 (06) :534-539

[27] Gegen Qinlian Tablets attenuate immune-related adverse events in NSCLC patients: A multi-center randomized controlled trial in China [J].

Lu, Xingyu ;

Wang, Aolin ;

Chen, Dongna ;

Yang, Meng ;

Zhang, Yongming ;

Liu, Meng ;

Zhang, Xiaoyan ;

Li, Yuan ;

Liu, Daiwei ;

Wang, Yunliang ;

Cheng, Zhiqiang ;

Li, Liya ;

Cui, Huijuan .

PHYTOMEDICINE, 2025, 145

[28] Long-term Efficacy and Safety of Mepolizumab in Patients With Severe Eosinophilic Asthma: A Multi-center, Open-label, Phase IIIb Study [J].

Lugogo, Njira ;

Domingo, Christian ;

Chanez, Pascal ;

Leigh, Richard ;

Gilson, Martyn J. ;

Price, Robert G. ;

Yancey, Steven W. ;

Ortega, Hector G. .

CLINICAL THERAPEUTICS, 2016, 38 (09) :2058-2070

[29] A randomized, open-label, parallel, multi-center Phase IV study to compare the efficacy and safety of atorvastatin 10 and 20 mg in high-risk Asian patients with hypercholesterolemia [J].

Kim, Ji Bak ;

Song, Woo Hyuk ;

Park, Jong Sung ;

Youn, Tae-Jin ;

Park, Yong Hyun ;

Kim, Shin-Jae ;

Ahn, Sung Gyun ;

Doh, Joon-Hyung ;

Cho, Yun-Hyeong ;

Kim, Jin Won .

PLOS ONE, 2021, 16 (01)

[30] Efficacy and safety of mitoxantrone hydrochloride liposome injection in Chinese patients with advanced breast cancer: a randomized, open-label, active-controlled, single-center, phase II clinical trial [J].

Wang, Leiping ;

Cao, Jun ;

Li, Chunlei ;

Wang, Xiaodong ;

Zhao, Yannan ;

Li, Ting ;

Du, Yiqun ;

Tao, Zhonghua ;

Peng, Wenxia ;

Wang, Biyun ;

Zhang, Jian ;

Zhang, Sheng ;

Wang, Zhonghua ;

Hu, Xichun .

INVESTIGATIONAL NEW DRUGS, 2022, 40 (02) :330-339

← 1 2 3 4 5 →